Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

Correction to: J Exp Clin Cancer Res 36, 172 (2017)

https://doi.org/10.1186/s13046-017-0635-9

Following publication of the original article [1], minor errors we identified in Fig. 6d and Fig. S4; specifically:

• Figure 6d: incorrect image used for shCtrl scratch image (24 h); correct image now used

• Fig. S4: incorrect images used for the invasive MDA-MB-231 cells (25 μM EA); correct images now used

Fig. 6.

ACTN4 promotes breast cancer proliferation and metastasis in vitro and in vivo. a Intracellular expression of ACTN4 was determined by Western blot (left) and real-time PCR (right) analysis, respectively; b ACTN4 expression was modified by transfecting recombinant plasmid or its shRNA in breast cancer cells and subjected to Western blotting (left) and real-time PCR (right) validation; c MTT and colony formation assay showed that ACTN4 silencing abrogated breast cancer cell proliferation while its overexpression promoted cell growth; d ACTN4 silencing inhibited the migration and invasion abilities of MDA-MB-231 cells; e ACTN4 silencing inhibited breast cancer growth and lung metastasis in vivo (*P < 0.05, **P < 0.01 versus control, values represented as the mean ± SD, n = 3)

The corrected figures, produced using the original data, are given here. The correction does not have any effect on the final conclusions of the paper.